Efficacy and safety of FRGP on improving blood glucose and serum cholesterol; A 12week, multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002583

Enrollment

Registered

2017-12-06

Start date

2016-11-16

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : The participants enrolled in this study was assigned to 2 groups by double-blinde randomization

Test group: FRGP 2cap * 2times/1day, 12 weeks Placebo group: placebo 2cap* 2times/1day, 12 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Adults aged 20 years old or more and less than 75 years old 2) Fasting glucose = 100 mg/dl and = 125 mg/dl 3) Subject who agrees to participate in the study and signs the informed consent form

Exclusion criteria

Exclusion criteria: 1) Subjects who had insulin therapy, and/or oral hypoglucosuric agent previously within 3 months before the trial 2) Subjects who took corticosteroid drug previously within 2 months before the trial 3) Subject with uncontrolled hypertension (over 170/100mmHg, when measuring after 10 minutes steady) 4) Subject with TSH =0.1uU/ml or = 10 uU/ml 5) Subject with AST(GOT) or ALT(GPT) or ?-GTP = 3 times the upper limit of normal 6) Inappropriate subject decided by the investigator

Design outcomes

Primary

Measure	Time frame
Fasting blood glucose	—

Secondary

Measure	Time frame
Total cholesterol, LDL-cholesterol, HDL-cholesterol ;Adverse Event ;Clinical pathology (hematology / blood chemical tests, urine tests)	—

Countries

Korea, Republic of

Contacts

Public Contactbelong Cho

Seoul National University Hospital

belong@gmail.com+82-2-2072-2195

Outcome results